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Contemporary medical science heavily relies on the 
use of technology. Part of this technology strives to im-
prove examination and measurement of the human body, 
with some of the most impressive technical breakthroughs 
to be found in the development of non-invasive proce-
dures. Another part focuses on the development of de-
vices that support therapies for specific pathologies. An 
example of this is the artificial kidney, which has become 
the target of intensive research from many directions and 
generates great expectations for dialysis patients. Re-
search on the artificial kidney is still incipient though, and 
there are many challenges that must be overcome before 
it will become a reality and part of clinical practice in ne-
phrology. One of these non-trivial challenges concerns 
the safety of users of these new dialysis devices. Safety 
risks make effective monitoring systems mandatory. 
A byproduct of the abundance of technological devic-
es surrounding the patient at the point of care is the con-
tinuous generation of data in electronic format, which, in 
turn, generates the need for analytical methods capable of 
transforming such data into knowledge that is ultimately 
useful for patients’ treatment. The field of artificial intel-
ligence (AI) is currently providing some of the most 
promising results as analytical tools. 
AI is an umbrella term that conveniently shelters con-
cepts from other fields such as statistics, algorithmics, 
machine learning (ML), information retrieval, and data 
science at large. It is precisely the advances in computa-
tional technologies that have enabled all fields of science 
to become data-rich environments. Medicine in particu-
lar is benefiting enormously from the advances resulting 
from data analysis using AI and related methods. The 
normalization of the use of electronic health records at 
the point of care allows these benefits to also permeate the 
healthcare sector.
The six papers in this issue of Kidney Diseases are the 
outcome of the Second Science for Dialysis Meeting: Ar-
tificial Intelligence, organized by the Hospital Universi-
tari de Bellvitge in Barcelona, Spain, in which the medical 
and AI research communities gathered to discuss how 
applications of AI may improve the safety of artificial kid-
neys. 
The current issue is organized in four parts. Part I is 
introductory and includes two papers: the first, by Hue-
so et al. [1], discusses the progresses and challenges of 
AI, ML, and medical decision support systems in their 
application to nephrology and to artificial kidneys; the 
second, by Vellido [2], delves into the many societal is-
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sues that face the application of AI in medical practice. 
Part II presents the concept of Reinforcement Learning, 
an area of ML inspired by goal-oriented algorithms 
which learn from interaction with the environment [3]. 
Part III includes two papers concerning AI and ML 
strategies to deal with blood pressure assessment and 
management by Ribas Ripoll and Vellido [4] and Barb-
ieri et al. [5]. The former uses Deep Learning techniques 
while the latter involves end-stage kidney disease pa-
tients. Finally, part IV presents experience with artificial 
pancreas, currently introduced in clinical practice, by 
Mishina [6], involving the individualization in the re-
sponse to dialysis treatment to improve dialysis dose ac-
curacy.
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